CDK4/6 inhibitor rechallenge therapy in advanced breast cancer
Crossref DOI link: https://doi.org/10.1007/s12672-025-04269-2
Published Online: 2025-12-20
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sun, Yuhan
Zhao, Yang
Yu, Xinyang
Qi, Yuanfu
Dai, Xin
Text and Data Mining valid from 2025-12-20
Version of Record valid from 2026-01-23
Article History
Received: 29 July 2025
Accepted: 9 December 2025
First Online: 20 December 2025
Declarations
:
: Not applicable.
: Yes.
: The authors declare no competing interests.